Generation of 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-) mouse line

被引:53
作者
Dragin, Nadine
Uno, Shigeyuki
Wang, Bin
Dalton, Timothy P.
Nebert, Daniel W.
机构
[1] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Med Ctr, CEG, Cincinnati, OH 45267 USA
关键词
humanized mouse line; human CYP1A1_1A2 locus; mouse Cyp1a1_1a2 locus; loxP; Cre recombinase; interchromosomal excision; benzo[a]pyrene; dioxin;
D O I
10.1016/j.bbrc.2007.05.202
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human/rodent CYP1A1 and CYP1A2 orthologs are well known to exhibit species-specific differences in substrate preferences and rates of metabolism. This lab previously characterized a BAC-transgenic mouse carrying the human CYP1A1_CYP1A2 locus; in this line, human dioxin-inducible CYP1A1 and basal vs dioxin-inducible CYP1A2 have been shown to be expressed normally (with regard to mRNAs, proteins and three enzyme activities) in every one of nine mouse tissues studied. The mouse Cyp1a1 and Cyp1a2 genes are oriented head-to-head and share a bidirectional promoter region of 13,954 bp. Using Cre recombinase and loxP sites inserted 3' of the stop codons of both genes, we show here a successful interchromosomal excision of 26,173 bp that ablated both genes on the same allele. The Cyp1a1/la2 (-) double-knockout allele was bred with the "humanized" line; the final product is the hCYP1A1_1A2_Cyp1a1/1a2(-/-) line on a theoretically > 99.8% C57BL/6J genetic background-having both human genes replacing the mouse orthologs. This line will be valuable for human risk assessment studies involving any environmental toxicant or drug that is a substrate for CYP1A1 or CYP1A2. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:635 / 642
页数:8
相关论文
共 37 条
[1]   HUMAN CDNA-EXPRESSED CYTOCHROME-P450 IA2 - MUTAGEN ACTIVATION AND SUBSTRATE-SPECIFICITY [J].
AOYAMA, T ;
GONZALEZ, FJ ;
GELBOIN, HV .
MOLECULAR CARCINOGENESIS, 1989, 2 (04) :192-198
[2]   SITE-SPECIFIC RECOMBINATION OF A TRANSGENE IN FERTILIZED-EGGS BY TRANSIENT EXPRESSION OF CRE RECOMBINASE [J].
ARAKI, K ;
ARAKI, M ;
MIYAZAKI, J ;
VASSALLI, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (01) :160-164
[3]   Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse [J].
Buchholz, F ;
Refaeli, Y ;
Trumpp, A ;
Bishop, JM .
EMBO REPORTS, 2000, 1 (02) :133-139
[4]   Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas [J].
Buters, JTM ;
Sakai, S ;
Richter, T ;
Pineau, T ;
Alexander, DL ;
Savas, U ;
Doehmer, J ;
Ward, JM ;
Jefcoate, CR ;
Gonzalez, FJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :1977-1982
[5]   Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure [J].
Chen, Ying ;
Yang, Yi ;
Miller, Marian L. ;
Shen, Dongxiao ;
Shertzer, Howard G. ;
Stringer, Keith F. ;
Wang, Bin ;
Schneider, Scott N. ;
Nebert, Daniel W. ;
Dalton, Timothy P. .
HEPATOLOGY, 2007, 45 (05) :1118-1128
[6]   Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2 [J].
Cheung, C ;
Ma, XC ;
Krausz, KW ;
Kimura, S ;
Feigenbaum, L ;
Dalton, TP ;
Nebert, DW ;
Idle, JR ;
Gonzalez, FJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (09) :1471-1478
[7]   Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene:: Embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous [J].
Dalton, TP ;
Dieter, MZ ;
Yang, Y ;
Shertzer, HG ;
Nebert, DW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (02) :324-329
[8]   Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery [J].
Dalton, TP ;
Dieter, MZ ;
Matlib, RS ;
Childs, NL ;
Shertzer, HG ;
Genter, MB ;
Nebert, DW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 267 (01) :184-189
[9]   Theophylline pharmacokinetics:: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice [J].
Derkenne, S ;
Curran, CP ;
Shertzer, HG ;
Dalton, TP ;
Dragin, N ;
Nebert, DW .
PHARMACOGENETICS AND GENOMICS, 2005, 15 (07) :503-511
[10]   Engineering de novo reciprocal chromosomal translocations associated with MII to replicate primary events of human cancer [J].
Forster, A ;
Pannell, R ;
Drynan, LF ;
McCormack, M ;
Collins, EC ;
Daser, A ;
Rabbitts, TH .
CANCER CELL, 2003, 3 (05) :449-458